Led · Series B · Mar 2026

AquaExchange builds hardware-enabled and software-driven products for shrimp and fish farmers, including PowerMon for power management and AquaBot for automated feed dispensing. Its platform monitors more than 80,000 acres of aquaculture ponds worldwide and is already automating over 25% of India’s shrimp-farming acreage. Beyond farm automation, the company connects growers to formal crop loans and working-capital facilities. AquaExchange operates across five Indian states and in international markets such as Ecuador, Saudi Arabia and Madagascar. For FY25, operating revenue grew 2.3× year-over-year to ₹240.51 crore, while losses widened to ₹12.71 crore; management expects to reach EBITDA profitability within the current fiscal year. Founders are Pavan Kosaraju, Hemasundar Dhavili, Kareem Mohammod and Kiran Bandi.

Led · Equity · Mar 2025

Asper.ai offers a proprietary AI for growth platform that enables interconnected and automated decisions across demand forecasting and planning, revenue growth management, inventory planning, and sales execution. The company is led by CEO Mohit Agarwal. It plans to use the new funding to expand its impact and enhance value for its customer base. Fractal made a $20M investment in Asper.ai. The platform targets consumer goods and manufacturing customers with integrated growth levers to drive planning and sales outcomes. The article does not disclose operating metrics such as revenue or user counts.

Participated · Series C · Mar 2022

Qure.ai is a global AI health innovator whose software analyses chest X-rays, CT scans, point-of-care ultrasounds, and other medical images to flag conditions such as tuberculosis, pneumonia, lung cancer, stroke, and other neuro-critical findings. The company’s platforms are deployed in more than 4,800 sites across 105+ countries, helping clinicians and health workers shorten TB diagnosis times from roughly two weeks to just one to two days, even in remote regions with limited clinical staff. Its technology is already used on Mount Everest, in sub-Saharan Africa, and rural Southeast Asia to bring diagnostics to hard-to-reach populations. Qure.ai’s product suite supports early disease detection, triage, and care-pathway management for both public-health programs and commercial healthcare providers. The firm also collaborates with pharmaceutical and medical-device companies to accelerate research and treatment developments. Looking ahead, Qure.ai plans to build an open-source, multi-modal database and new AI algorithms for point-of-care ultrasound, further expanding its lung-health capabilities. Although the article does not disclose current revenue figures, the multimillion-dollar Gates Foundation grant underscores external confidence in Qure.ai’s impact and future growth trajectory.

Led · Equity · Aug 2021

Senseforth.ai offers A.ware, a patented, zero‑code conversational AI platform that automates customer experience across digital touchpoints and makes it easy to build, train, deploy, and scale bots. The company says A.ware is industry agnostic and is already automating billions of conversations and handling millions of conversations every month via 100+ implemented solutions. Senseforth.ai positions the product as revenue‑driving and cost‑reducing for enterprises and highlights strong ML performance (SQuAD 2.0 leaderboard). The company has been recognized as a ‘Cool Vendor’ in Conversational AI Platforms by Gartner. Management plans to scale talent, accelerate growth, and make further R&D investments to strengthen deep learning capabilities and the platform.